Courage Capital Management LLC Editas Medicine, Inc. Transaction History

Courage Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$14.08 - $27.63 $126,720 - $248,670	-9,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$31.29 - $56.64 $125,160 - $226,560	4,000 Added 80.0%	9,000 $510,000
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $135,350 - $421,750	5,000 New	5,000 $351,000
Q3 2018 Nov 14, 2018	SELL	$27.65 - $38.39 $232,260 - $322,476	-8,400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$31.4 - $41.01 $65,940 - $86,121	2,100 Added 33.33%	8,400 $301,000
Q4 2017 Feb 14, 2018	BUY	$21.89 - $31.34 $137,907 - $197,442	6,300	6,300 $194,000

250

57.1M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $83.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Courage Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Courage Capital Management LLC with notifications on news.